grepcent public filings, reorganized for comparison

ORGO profile · all as-reported value updates

Organogenesis Holdings Inc. (ORGO) as-reported value updates

Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.

Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.

Rows publish only when the later filed value differs by at least 1.0% and at least $1,000,000, after dropping differences that match under the capped trailing-zero precision rule. The delta percent is delta divided by the larger absolute filed value. Values are annual standardized facts only; metrics whose differences fall below those thresholds or match the capped precision rule are not published as rows.

Ledger table figure

ORGO as-reported XBRL value updates. Compact figure; full filing links are in the page table.ORGO as-reported XBRL value updates. Compact figure; full filing links are in the page table.MetricFYThenNowDeltaDelta %Stockholders' equity2017$5.0M-$15.3M-$20.3M-132.64%Stockholders' equity2016$5.0M-$16.0M-$21.0M-131.29%Net income2016-$208.7K-$17.0M-$16.8M-98.77%Operating income2016-$208.7K-$8.8M-$8.6M-97.62%Liabilities2017$14.8M$157.3M$142.5M+90.60%Operating cash flow2016-$562.2K-$4.9M-$4.3M-88.46%Operating cash flow2017-$586.6K-$3.5M-$2.9M-83.21%Net income2017-$2.1M-$8.4M-$6.3M-75.04%
MetricFYEarliest XBRL-filed valueCurrently on fileDifferenceDifference %LabelFiling linksNotes
Stockholders' equity
StockholdersEquity
20175,000,008
filed 2018-03-14 · 10-K
-15,317,000
filed 2021-03-16 · 10-K
-20,317,008-132.64%revised comparative figure0001558370-18-002068
0001193125-21-082849
4 filed observations examined for this concept and period.
Stockholders' equity
StockholdersEquity
20165,000,001
filed 2017-03-28 · 10-K
-15,979,000
filed 2020-03-09 · 10-K
-20,979,001-131.29%revised comparative figure0001047469-17-002096
0001193125-20-067198
4 filed observations examined for this concept and period.
Net income
NetIncomeLoss
2016-208,698
filed 2017-03-28 · 10-K
-16,987,000
filed 2019-03-18 · 10-K
-16,778,302-98.77%revised comparative figure0001047469-17-002096
0001193125-19-078332
3 filed observations examined for this concept and period.
Operating income
OperatingIncomeLoss
2016-208,698
filed 2018-03-14 · 10-K
-8,775,000
filed 2019-03-18 · 10-K
-8,566,302-97.62%revised comparative figure0001558370-18-002068
0001193125-19-078332
2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing.
Liabilities
Liabilities
201714,778,722
filed 2018-03-14 · 10-K
157,277,000
filed 2019-03-18 · 10-K
142,498,278+90.60%revised comparative figure0001558370-18-002068
0001193125-19-078332
2 filed observations examined for this concept and period.
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
2016-562,233
filed 2018-03-14 · 10-K
-4,871,000
filed 2019-03-18 · 10-K
-4,308,767-88.46%revised comparative figure0001558370-18-002068
0001193125-19-078332
2 filed observations examined for this concept and period. Earliest observation is a comparative value in a later annual filing.
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
2017-586,604
filed 2018-03-14 · 10-K
-3,493,000
filed 2020-03-09 · 10-K
-2,906,396-83.21%revised comparative figure0001558370-18-002068
0001193125-20-067198
3 filed observations examined for this concept and period.
Net income
NetIncomeLoss
2017-2,093,913
filed 2018-03-14 · 10-K
-8,388,000
filed 2020-03-09 · 10-K
-6,294,087-75.04%revised comparative figure0001558370-18-002068
0001193125-20-067198
3 filed observations examined for this concept and period.
Assets
Assets
2017312,792,360
filed 2018-03-14 · 10-K
148,722,000
filed 2019-03-18 · 10-K
-164,070,360-52.45%revised comparative figure0001558370-18-002068
0001193125-19-078332
2 filed observations examined for this concept and period.
Operating cash flow
NetCashProvidedByUsedInOperatingActivities
20206,801,000
filed 2021-03-16 · 10-K
5,466,000
filed 2023-03-01 · 10-K
-1,335,000-19.63%revised comparative figure0001193125-21-082849
0000950170-23-005585
3 filed observations examined for this concept and period.
Capital expenditures
PaymentsToAcquirePropertyPlantAndEquipment
202021,145,000
filed 2021-03-16 · 10-K
17,678,000
filed 2023-03-01 · 10-K
-3,467,000-16.40%revised comparative figure0001193125-21-082849
0000950170-23-005585
3 filed observations examined for this concept and period.
Stockholders' equity
StockholdersEquity
201847,041,000
filed 2019-03-18 · 10-K
39,939,000
filed 2022-03-01 · 10-K
-7,102,000-15.10%revised comparative figure0001193125-19-078332
0001193125-22-061686
4 filed observations examined for this concept and period.
Stockholders' equity
StockholdersEquity
201955,583,000
filed 2020-03-09 · 10-K
52,022,000
filed 2023-03-01 · 10-K
-3,561,000-6.41%revised comparative figure0001193125-20-067198
0000950170-23-005585
4 filed observations examined for this concept and period.
Net income
NetIncomeLoss
2019-40,454,000
filed 2020-03-09 · 10-K
-38,709,000
filed 2022-03-01 · 10-K
1,745,000+4.31%revised comparative figure0001193125-20-067198
0001193125-22-061686
3 filed observations examined for this concept and period.
Stockholders' equity
StockholdersEquity
2020146,084,000
filed 2021-03-16 · 10-K
141,808,000
filed 2024-02-29 · 10-K
-4,276,000-2.93%revised comparative figure0001193125-21-082849
0000950170-24-023150
4 filed observations examined for this concept and period.
Assets
Assets
2020294,494,000
filed 2021-03-16 · 10-K
290,218,000
filed 2022-03-01 · 10-K
-4,276,000-1.45%revised comparative figure0001193125-21-082849
0001193125-22-061686
2 filed observations examined for this concept and period.